197 related articles for article (PubMed ID: 16887059)
21. The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice.
Takato H; Yasui M; Ichikawa Y; Waseda Y; Inuzuka K; Nishizawa Y; Tagami A; Fujimura M; Nakao S
Exp Lung Res; 2011 Mar; 37(2):101-8. PubMed ID: 21128860
[TBL] [Abstract][Full Text] [Related]
22. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
[TBL] [Abstract][Full Text] [Related]
23. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats.
Zhou XM; Zhang GC; Li JX; Hou J
J Ethnopharmacol; 2007 May; 111(2):255-64. PubMed ID: 17188826
[TBL] [Abstract][Full Text] [Related]
25. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro.
Liu J; Wang X; Wang F; Teng L; Cao J
Biomed Pharmacother; 2009 Aug; 63(7):484-91. PubMed ID: 18602243
[TBL] [Abstract][Full Text] [Related]
26. Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Exp Lung Res; 2010 Jun; 36(5):292-301. PubMed ID: 20497024
[TBL] [Abstract][Full Text] [Related]
27. Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondin.
Azuma A; Li YJ; Abe S; Usuki J; Matsuda K; Henmi S; Miyauchi Y; Ueda K; Izawa A; Sone S; Hashimoto S; Kudoh S
Am J Respir Cell Mol Biol; 2005 Feb; 32(2):93-8. PubMed ID: 15557019
[TBL] [Abstract][Full Text] [Related]
28. [Experimental study on effect of Huaxian Decoction treating bleomycin-induced pulmonary fibrosis in mice].
Wang SJ; Bai W; Wang CL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Apr; 27(4):347-51. PubMed ID: 17526177
[TBL] [Abstract][Full Text] [Related]
29. [A preliminary study of CTGF in bleomycin-induced mouse pulmonary fibrosis].
Zhang L; Lu HP; Lai GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):290-2. PubMed ID: 15862142
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
31. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
Wang Q; Hyde DM; Gotwals PJ; Giri SN
Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
[TBL] [Abstract][Full Text] [Related]
32. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
33. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
35. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
Manoury B; Nénan S; Guénon I; Lagente V; Boichot E
Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
[TBL] [Abstract][Full Text] [Related]
36. [An experimental observation of pulmonary fibrosis in rats and its transforming growth factor beta1 treated by total hedysarum polybotyssaccharide].
Lei FF; Zhao JX; Wang XX; Yao BT; Ding K
Zhong Yao Cai; 2008 Jun; 31(6):873-7. PubMed ID: 18998573
[TBL] [Abstract][Full Text] [Related]
37. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis.
Zhao L; Wang X; Chang Q; Xu J; Huang Y; Guo Q; Zhang S; Wang W; Chen X; Wang J
Eur J Pharmacol; 2010 Feb; 627(1-3):304-12. PubMed ID: 19909737
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of nitric oxide synthase by the endothelium attenuates bleomycin-induced lung fibrosis and impairs MMP-9/TIMP-1 balance.
Yoshimura S; Nishimura Y; Nishiuma T; Yamashita T; Kobayashi K; Yokoyama M
Respirology; 2006 Sep; 11(5):546-56. PubMed ID: 16916326
[TBL] [Abstract][Full Text] [Related]
40. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
